1 Antithrombotische und thrombolytische Behandlung: Internationale EBM-Guidelines, kommentiert von Schweizer Experten. The 7th ACCP Conference on Antithrombotic and Thrombolytic therapy. Swiss Med Forum. 2005;5(Suppl.27):1–48S.
2 Traitement antithrombotique et thrombolytique: Commentaire des experts suisses concernant les «EBM-guidelines» internationales. 7th ACCP Conference on Antithrombotic and Thrombolytic therapy. Forum Med Suisse. 2005;5(Suppl.28):1–48S.
3 Wuillemin WA, Spirk D, Beer JH, Baumgartner I. Schweizer Expertenkommentare zum Update der ACCP-Guidelines. Swiss Med Forum. 2016;16(49–50):1059–60.
4 Wuillemin WA, Spirk D, Beer JH, Baumgartner I. Commentaires d’experts suisses sur la mise à jour des recommandations ACCP. Forum Med Suisse. 2016;16(49–50):1059–60.
5 Engelberger RP, Stricker H, Mazzolai L, Kucher N. Behandlung der venösen Thromboembolie, Fokus Lungenembolie. Swiss Med Forum. 2016;16(49–50):1062–6.
6 Engelberger RP, Stricker H, Mazzolai L, Kucher N. Traitement de la thromboembolie veineuse – focus sur l’embolie pulmonaire. Forum Med Suisse. 2016;16(49–50):1062–6.
7 Engelberger RP, Stricker H, Mazzolai L, Kucher N. Behandlung der venösen Thromboembolie, Fokus tiefe Venenthrombose. Swiss Med Forum. 2017;17(35):732–6.
8 Engelberger RP, Stricker H, Mazzolai L, Kucher N. Behandlung der venösen Thromboembolie – focus sur la thrombose veineuse profonde. Forum Med Suisse. 2017;17(35):732–6.
9 Lim W, Le Gal G, Bates SM, Righini M, Haramati LB, Lang E, et. al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: diagnosis of venous thromboembolism. Blood Adv. 2018;2(22):3226–56.
10 Witt DM, Nieuwlaat R, Clark NP, Ansell J, Holbrook A, Skov J, et. al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy. Blood Adv. 2018;2(22):3257–91.
11 Schünemann HJ, Cushman M, Burnett AE, Kahn SR, Beyer-Westendorf J, Spencer FA, et. al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients. Blood Adv. 2018;2(22):3198–225.
12 Monagle P, Cuello CA, Augustine C, Bonduel M, Brandão LR, Capman T, et. al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism. Blood Adv. 2018;2(22):3292–316.
13 Bates SM, Rajasekhar A, Middeldorp S, McLintock C, Rodger MA, James AH, et. al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy. Blood Adv. 2018;2(22):3317–59.
14 Cuker A, Arepally GM, Chong BH, Cines DB, Greinacher A, Gruel Y, et. al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia. Blood Adv. 2018;2(22):3360–92.
15 Anderson DR, Morgano GP, Bennett C, Dentali F, Francis CW, Garcia DA, et al. American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients. Blood Adv. 2019;3(23):3898–944.
16 Lyman GH, Carrier M, Ay C, Di Nisio M, Hicks LK, Khorana AA, et al. American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer. Blood Adv. 2021;5(4):927–74.
17 Alberio LA, Angelillo-Scherrer A, Asmis LM, Casini A, Fontana P, Graf L, et al. Recommendations on the use of anticoagulants for the treatment of patients with heparin-induced thrombocytopenia (HIT) in Switzerland. Swiss Med Wkly. 2020;150:w20210.
18 Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing GJ, Harjola VP, et. al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J. 2020;41(4):543–603.